NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) had its target price reduced by research analysts at BMO Capital Markets from C$5.50 to C$5.25 in a report released on Tuesday,BayStreet.CA reports. BMO Capital Markets' price objective would indicate a potential upside of 8.47% from the company's current price.
NWH.UN has been the topic of several other reports. CIBC dropped their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.75 to C$5.50 in a report on Thursday, August 15th. National Bankshares set a C$5.50 price objective on NorthWest Health Prop Real Est Inv Trust and gave the stock a "sector perform" rating in a research note on Wednesday, September 4th.
Get Our Latest Stock Analysis on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Trading Down 1.0 %
Shares of TSE NWH.UN traded down C$0.05 during midday trading on Tuesday, hitting C$4.84. The stock had a trading volume of 440,490 shares, compared to its average volume of 654,420. The company has a market capitalization of C$1.19 billion, a price-to-earnings ratio of -3.04, a PEG ratio of 0.74 and a beta of 1.05. NorthWest Health Prop Real Est Inv Trust has a 1-year low of C$3.93 and a 1-year high of C$5.88. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The company has a fifty day moving average price of C$5.32 and a 200 day moving average price of C$5.10.
NorthWest Health Prop Real Est Inv Trust Company Profile
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
